Capillary Disease disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: CPL005 MIFTS: 38	Capillary Disease Categories: Cardiovascular diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs Download Expand all tables

Sources

Aliases & Classifications for Capillary Disease

MalaCards integrated aliases for Capillary Disease:

Name: Capillary Disease ¹² ¹⁵

Disease of Capillaries ¹² ⁷³

Classifications:

MalaCards categories:
Anatomical: Cardiovascular diseases

See all MalaCards categories (disease lists)

ICD10: ³³

Diseases of the circulatory system

Diseases of arteries, arterioles and capillaries

Diseases of capillaries

Disease of capillaries, unspecified

External Ids:

Disease Ontology ¹² DOID:1271

ICD10 ³³ I78 I78.9

ICD9CM ³⁵ 448

SNOMED-CT ⁶⁸ 155446001 155449008 195250004 more

UMLS ⁷³ C0155765

Sources

Summaries for Capillary Disease

Disease Ontology : ¹² A vascular disease that is located in the capillaries.

MalaCards based summary : Capillary Disease, also known as disease of capillaries, is related to burns and eosinophilic gastroenteritis, and has symptoms including petechiae of skin An important gene associated with Capillary Disease is IL2 (Interleukin 2), and among its related pathways/superpathways are Photodynamic therapy-induced NF-kB survival signaling and Cytokines and Inflammatory Response. The drugs Bosentan and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include the capillaries, bone and bone marrow.

Sources

Related Diseases for Capillary Disease

Diseases related to Capillary Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 77)

#	Related Disease	Score	Top Affiliating Genes
1	burns	10.5	ALB CSF2
2	eosinophilic gastroenteritis	10.5	ALB CSF2
3	pure red-cell aplasia	10.5	ALB IL2
4	hydrops, lactic acidosis, and sideroblastic anemia	10.4	ALB SERPING1
5	smallpox	10.4	CSF2 IL2
6	filariasis	10.3	ALB IL2
7	pulmonary sarcoidosis	10.2	CSF2 IL2
8	capillary leak syndrome	10.2	ALB CSF2 IL2
9	leukocyte disease	10.2	ALB CSF2 IL2
10	acquired immunodeficiency syndrome	10.2	ALB CSF2 IL2
11	immune system disease	10.2	ALB CSF2 IL2
12	lymphoma, hodgkin, classic	10.2	CSF2 IL2
13	mastitis	10.2	ALB CSF2
14	mucositis	10.1	CSF2 IL2
15	myeloma, multiple	10.1	ALB CSF2 IL2
16	microscopic colitis	10.0	ATP12A IL2
17	primary bacterial infectious disease	10.0	ALB IL2
18	hereditary hemorrhagic telangiectasia	9.9
19	fungal esophagitis	9.9	ATP12A ATP4A
20	bladder calculus	9.9	ATP12A ATP4A
21	gastrointestinal neuroendocrine benign tumor	9.9	ATP12A ATP4A
22	neonatal candidiasis	9.9	ATP12A ATP4A
23	photoallergic dermatitis	9.9	ATP12A ATP4A
24	squamous papillomatosis	9.9	ATP12A ATP4A
25	acute laryngitis	9.9	ATP12A ATP4A
26	gastroduodenal crohn's disease	9.9	ATP12A ATP4A
27	gastric neuroendocrine neoplasm	9.9	ATP12A ATP4A
28	toxic megacolon	9.9	ATP12A ATP4A
29	aspiration pneumonitis	9.9	ATP12A ATP4A
30	postsurgical hypothyroidism	9.9	ATP12A ATP4A
31	gastric antral vascular ectasia	9.9	ATP12A ATP4A
32	esophageal candidiasis	9.9	ATP12A ATP4A
33	duodenitis	9.9	ATP12A ATP4A
34	rumination disorder	9.9	ATP12A ATP4A
35	bile reflux	9.9	ATP12A ATP4A
36	granulomatous gastritis	9.9	ATP12A ATP4A
37	active peptic ulcer disease	9.9	ATP12A ATP4A
38	laryngeal disease	9.9	ATP12A ATP4A
39	ischemic neuropathy	9.9	ATP12A ATP4A
40	peptic esophagitis	9.9	ATP12A ATP4A
41	duodenal disease	9.9	ATP12A ATP4A
42	dyskinesia of esophagus	9.9	ATP12A ATP4A
43	hernia, hiatus	9.9	ATP12A ATP4A
44	congenital disorder of deglycosylation	9.8	ATP12A ATP4A
45	anismus	9.8	ATP12A ATP4A
46	esophageal atresia/tracheoesophageal fistula	9.8	ATP12A ATP4A
47	laryngitis	9.8	ATP12A ATP4A
48	laryngeal tuberculosis	9.8	ATP12A ATP4A
49	lymphocytic colitis	9.8	ATP12A ATP4A
50	clostridium difficile colitis	9.8	ATP12A ATP4A

Graphical network of the top 20 diseases related to Capillary Disease:

Sources

Symptoms & Phenotypes for Capillary Disease

UMLS symptoms related to Capillary Disease:

petechiae of skin

Sources

Drugs & Therapeutics for Capillary Disease

Drugs for Capillary Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 264)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Bosentan

Approved, Investigational

Phase 4,Phase 2

147536-97-8

104865

Dexamethasone

Approved, Investigational, Vet_approved

Phase 4,Phase 2,Phase 3

50-02-2

5743

rituximab

Approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

174722-31-7

10201696

Prednisone

Approved, Vet_approved

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

53-03-2

5865

Methylprednisolone

Approved, Vet_approved

Phase 4,Phase 2,Phase 3,Not Applicable

83-43-2

6741

Prednisolone

Approved, Vet_approved

Phase 4,Phase 2,Phase 3,Not Applicable

50-24-8

5755

Amoxicillin

Approved, Vet_approved

Phase 4,Phase 2,Phase 3

26787-78-0

33613

Clarithromycin

Approved

Phase 4,Phase 2,Phase 3

81103-11-9

84029

Dexlansoprazole

Approved, Investigational

Phase 4

138530-94-6, 103577-45-3

9578005

Lansoprazole

Approved, Investigational

Phase 4

103577-45-3

3883

Angiotensin II

Approved, Investigational

Phase 4

68521-88-0, 4474-91-3, 11128-99-7

172198 65143

Valsartan

Approved, Investigational

Phase 4

137862-53-4

60846

Azathioprine

Approved

Phase 4,Phase 3,Not Applicable

446-86-6

2265

Hydroxychloroquine

Approved

Phase 4

118-42-3

3652

Vincristine

Approved, Investigational

Phase 4,Phase 2,Phase 3

2068-78-2, 57-22-7

5978

Bisoprolol

Approved

Phase 4

66722-44-9

2405

Candesartan cilexetil

Approved

Phase 4

145040-37-5

2540

Captopril

Approved

Phase 4

62571-86-2

44093

Carvedilol

Approved, Investigational

Phase 4

72956-09-3

2585

Cilazapril

Approved

Phase 4

88768-40-5, 92077-78-6

56329 56330

Enalapril

Approved, Vet_approved

Phase 4

75847-73-3

5362032 40466924

Enalaprilat

Approved

Phase 4

76420-72-9

6917719

Eprosartan

Approved

Phase 4

133040-01-4

5281037

Fosinopril

Approved

Phase 4

98048-97-6

55891

Irbesartan

Approved, Investigational

Phase 4

138402-11-6

3749

Lisinopril

Approved, Investigational

Phase 4

83915-83-7, 76547-98-3

5362119

Losartan

Approved

Phase 4

114798-26-4

3961

Nebivolol

Approved, Investigational

Phase 4

152520-56-4, 99200-09-6, 118457-14-0

71301

Perindopril

Approved

Phase 4

107133-36-8, 82834-16-0

107807

Quinapril

Approved, Investigational

Phase 4

85441-61-8

54892

Ramipril

Approved

Phase 4

87333-19-5

5362129

Spirapril

Approved

Phase 4

83647-97-6

5311447

Trandolapril

Approved

Phase 4

87679-37-6

5484727

Caffeic acid

Experimental, Investigational

Phase 4,Phase 3

331-39-5

1549111

Candesartan

Experimental

Phase 4

139481-59-7

2541

Antihypertensive Agents

Phase 4,Phase 2

Endothelin Receptor Antagonists

Phase 4,Phase 2

Antiemetics

Phase 4,Phase 2,Phase 3,Not Applicable

Anti-Inflammatory Agents

Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1

Antineoplastic Agents, Hormonal

Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1

Antioxidants

Phase 4,Phase 2,Phase 3,Early Phase 1

Autonomic Agents

Phase 4,Phase 2,Phase 3,Not Applicable

BB 1101

Phase 4,Phase 2,Phase 3

Dexamethasone acetate

Phase 4,Phase 2,Phase 3

1177-87-3

Gastrointestinal Agents

Phase 4,Phase 2,Phase 3,Not Applicable

glucocorticoids

Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1

HIV Protease Inhibitors

Phase 4,Phase 2,Phase 3

Hormone Antagonists

Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1

Hormones

Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1

Hormones, Hormone Substitutes, and Hormone Antagonists

Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 352)

#	Name	Status	NCT ID	Phase	Drugs
1	The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis	Unknown status	NCT02480335	Phase 4	bosentan
2	Caffeic Acid Combining High-dose Dexamethasone in Management of ITP	Unknown status	NCT02556814	Phase 4	Caffeic acid tablets;Dexamethasone;placebo
3	Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study	Completed	NCT00460213	Phase 4	Valsartan 80mg daily;Valsartan 160mg daily
4	PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs	Completed	NCT02249897	Phase 4	CHOLESTYRAMINE
5	Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia	Completed	NCT03229746	Phase 4	Hydroxychloroquine;vincristine;azathioprine
6	The Study of Different Dose Rituximab in the Treatment of ITP	Completed	NCT03258866	Phase 4	Rituximab;Rituximab
7	A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)	Completed	NCT01390649	Phase 4
8	High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)	Completed	NCT01356511	Phase 4	Prednisone;Dexamethasone
9	A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)	Completed	NCT01098487	Phase 4	Eltrombopag olamine
10	Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)	Completed	NCT00907478	Phase 4
11	Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag	Completed	NCT00888901	Phase 4	eltrombopag;corticosteroids (Aprednislon)
12	Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura	Completed	NCT00467571	Phase 4	lansoprazole, clarithromycin, amoxycillin
13	NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients	Recruiting	NCT02817360	Phase 4	RAS-antagonist and beta-blocker up-to maximal dosages
14	The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia	Recruiting	NCT03201848	Phase 4	Placebo;Huaiqihuang Granule
15	Immunomodulation With Romiplostim in Young Adults With ITP	Recruiting	NCT02760251	Phase 4	romiplostim
16	Eval. of Potential Predictors of Disease Progression in Patients With aHUS Including Genetics, Biomarkers and Treatment	Active, not recruiting	NCT02614898	Phase 4
17	Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS	Active, not recruiting	NCT02574403	Phase 4	eculizumab
18	Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura	Not yet recruiting	NCT03172676	Phase 4	Amoxicillin 50 mg/kg/day in 2 divided doses for 14 days.;Clarithromycin 15 mg/kg/day in 2 divided doses for 14 days.;Proton pump inhibitor 1 mg/kg/day in 2 divided doses 1 month
19	Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)	Withdrawn	NCT02642380	Phase 4	Dexamethasone (4 cycles);Dexamethasone (1 cycle)
20	Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura	Withdrawn	NCT01754545	Phase 4	Octaplas infusion and placebo (group 1);Octaplas infusion and placebo (group 2)
21	Thrombocytopenia in Gestational Period	Unknown status	NCT02751593	Phase 2, Phase 3	Dexamethasone
22	A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy	Unknown status	NCT02391272	Phase 3	rhTPO
23	Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy	Unknown status	NCT02270801	Phase 3	rhTPO
24	Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia	Unknown status	NCT01763658	Phase 2, Phase 3	Antox tablets(Mepaco)
25	Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP	Unknown status	NCT01805648	Phase 3	rhTPO
26	The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)	Unknown status	NCT00909077	Phase 3	Dexamethasone;Dexamethasone and Rituximab
27	Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDY	Completed	NCT01295736	Phase 3	Sildenafil;placebo
28	Effects of Saxagliptin on Endothelial Function	Completed	NCT01319357	Phase 3	Saxagliptin;Placebo
29	Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch	Completed	NCT00275509	Phase 3	Thymoglobulin;Daclizumab;Mycophenolate mofetil;Tacrolimus;Dexamethasone;Prednisone;Cytogam
30	Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)	Completed	NCT00406393	Phase 3	Tacrolimus;Methotrexate;Sirolimus
31	Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)	Completed	NCT02868099	Phase 3	Romiplostim;Placebo
32	Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone	Completed	NCT02914054	Phase 2, Phase 3	High dose Dexamethasone pulses;Prednisone
33	Caffeic Acid Tablets as a Second-line Therapy for ITP	Completed	NCT02351622	Phase 3	Caffeic acid;Dexamethasone;Placebo
34	Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura	Completed	NCT02553317	Phase 3
35	An Investigation of rhTPO With Different Frequencies in the Management of ITP	Completed	NCT02139501	Phase 3	Recombinant Human Thrombopoietin (rhTPO)
36	An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia	Completed	NCT02063789	Phase 3	Human immunoglobulin intravenous
37	Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia	Completed	NCT02334813	Phase 3	Prednisone;Dexamethasone
38	A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)	Completed	NCT02201290	Phase 3	Eltrombopag Tablets;Eltrombopag PfOS
39	A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)	Completed	NCT02076412	Phase 3	Fostamatinib Disodium 100mg;Placebo;Fostamatinib Disodium 150mg
40	A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)	Completed	NCT02076399	Phase 3	Fostamatinib Disodium 100mg;Placebo;Fostamatinib Disodium 150mg
41	rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP	Completed	NCT01734044	Phase 3	recombinant human thrombopoietin (rhTPO); dexamethasone;Dexamethasone
42	Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients	Completed	NCT01730352	Phase 2, Phase 3	H. pylori triple therapy
43	Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)	Completed	NCT01438840	Phase 3	Avatrombopag;Placebo;Standard of care
44	Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia	Completed	NCT01349790	Phase 3	NewGam
45	rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP	Completed	NCT01525836	Phase 3	rituximab; recombinant human thrombopoietin (rhTPO);Rituximab
46	Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.	Completed	NCT01520909	Phase 3	Eltrombopag;Placebo
47	Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)	Completed	NCT01506414	Phase 3	rhTPO in combination with Rituximab
48	Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients	Completed	NCT01444417	Phase 3	Romiplostim;Placebo
49	Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)	Completed	NCT01410916	Phase 2, Phase 3	Eculizumab (Soliris®)
50	A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune (Idiopathic) Thrombocytopenia Purpura	Completed	NCT01071954	Phase 3

Search NIH Clinical Center for Capillary Disease

Sources

Genetic Tests for Capillary Disease

Sources

Anatomical Context for Capillary Disease

The Foundational Model of Anatomy Ontology organs/tissues related to Capillary Disease:

¹⁹

The Capillaries

MalaCards organs/tissues related to Capillary Disease:

⁴¹

Bone, Bone Marrow, Endothelial, Testes, Kidney, B Cells, T Cells

Sources

Publications for Capillary Disease

Articles related to Capillary Disease:

#	Title	Authors	Year
1	Growth hormone, sorbitol, and diabetic capillary disease. ( 4102056 )	Gabbay K.H....Kinoshita J.H.	1971
2	Growth hormone, sorbitol, and diabetic capillary disease. ( 4100908 )	Beaumont P....Williams J.F.	1971

Sources

Genes for Capillary Disease

Genes related to Capillary Disease (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	IL2	Interleukin 2	Protein Coding	17.12	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
2	SERPING1	Serpin Family G Member 1	Protein Coding	16.25	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
3	CSF2	Colony Stimulating Factor 2	Protein Coding	15.5	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
4	ALB	Albumin	Protein Coding	15.27	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
5	ARHGAP5	Rho GTPase Activating Protein 5	Protein Coding	14.98	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
6	STAMBP	STAM Binding Protein	Protein Coding	14.72	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
7	ECI1	Enoyl-CoA Delta Isomerase 1	Protein Coding	14.62	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
8	ATP12A	ATPase H+/K+ Transporting Non-Gastric Alpha2 Subunit	Protein Coding	14.56	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
9	ATP4A	ATPase H+/K+ Transporting Subunit Alpha	Protein Coding	14.55	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)

Sources

Variations for Capillary Disease

Sources

Expression for Capillary Disease

Search GEO for disease gene expression data for Capillary Disease.

Sources

Pathways for Capillary Disease

Pathways related to Capillary Disease according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Photodynamic therapy-induced NF-kB survival signaling ¹ Show member pathways Immune response MIF-mediated glucocorticoid regulation ²²	10.76	CSF2 IL2
2	Cytokines and Inflammatory Response ¹	10.1	CSF2 IL2

Sources

GO Terms for Capillary Disease

Cellular components related to Capillary Disease according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	extracellular space	GO:0005615	9.02	ALB ATP4A CSF2 IL2 SERPING1

Biological processes related to Capillary Disease according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	potassium ion import	GO:0010107	9.37	ATP12A ATP4A
2	ATP hydrolysis coupled proton transport	GO:0015991	9.32	ATP12A ATP4A
3	cellular sodium ion homeostasis	GO:0006883	9.26	ATP12A ATP4A
4	cellular potassium ion homeostasis	GO:0030007	9.16	ATP12A ATP4A
5	sodium ion export across plasma membrane	GO:0036376	8.96	ATP12A ATP4A
6	establishment or maintenance of transmembrane electrochemical gradient	GO:0010248	8.62	ATP12A ATP4A

Molecular functions related to Capillary Disease according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	sodium:potassium-exchanging ATPase activity	GO:0005391	8.96	ATP12A ATP4A
2	potassium:proton exchanging ATPase activity	GO:0008900	8.62	ATP12A ATP4A

Sources

Sources for Capillary Disease

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia